Cargando…
Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells
This paper describes a bi-specific antibody, which was called BIS20x3. It retargets CD3ɛ-positive cells (T-cells) to CD20-positive cells and was obtained by hybrid–hybridoma fusion. BIS20x3 could be isolated readily from quadroma culture supernatant and retained all the signalling characteristics as...
Autores principales: | Withoff, S, Bijman, M N A, Stel, A J, Delahaye, L, Calogero, A, Jonge, M W A de, Kroesen, B J, Leij, L de |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363855/ https://www.ncbi.nlm.nih.gov/pubmed/11308263 http://dx.doi.org/10.1054/bjoc.2000.1707 |
Ejemplares similares
-
CD3 directed bispecific antibodies induce increased lymphocyte–endothelial cell interactions in vitro
por: Molema, G, et al.
Publicado: (2000) -
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.
por: Janssen, R. A., et al.
Publicado: (1995) -
Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
por: Boissel, Laurent, et al.
Publicado: (2013) -
Keratin 20 Expressed in the Endocrine and Exocrine Cells of the Rabbit Duodenum
por: Iwatsuki, Hirohiko, et al.
Publicado: (2007) -
Retargeted adenoviruses for radiation-guided gene delivery
por: Kaliberov, S A, et al.
Publicado: (2016)